ReviewTechnology in cancer research & treatment
Research Progress on Dual-Modal Fluorescence-MRI Molecular Imaging of Molecular Probes in Breast Cancer.
Review in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer (BC), as a prevalent malignancy among women worldwide, requires early and precise diagnosis to improve patient prognosis. This review systematically summarizes the recent research progress of fluorescence -magnetic resonance (MR) dual-modal molecular probes in the diagnosis and treatment of breast cancer, focuses on introducing three major design strategies of the probes, and analyzes their synergistic advantages in tumor localization, metastatic lesion detection, intraoperative navigation, dynamic drug monitoring, and other aspects. Studies have shown that by combining the high-resolution anatomical information of MRI with the high-sensitivity dynamic tracking of fluorescence imaging (FI), FI-MRI dual-modal molecular imaging significantly improves the accuracy of early diagnosis and treatment visualization, and can provide an important reference for formulating precise diagnosis and treatment strategies for breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.